Opexa Amends Agreement with Merck Serono and Receives Additional $3 Million Payment to Support Ongoing Development of Tcelna® for Multiple Sclerosis
Opexa Therapeutics, 9 Mar 2015
Accessed on 10 Mar 2015 from http://www.opexatherapeutics.com/news-and-resources/press-releases/press-releases-details/2015/Opexa-Amends-Agreement-with-Merck-Serono-and-Receives-Additional-3-Million-Payment-to-Support-Ongoing-Development-of-Tcelna-for-Multiple-Sclerosis/default.aspx.